ConductScience.org, home

Library / Genes

IKZF1: IKAROS family zinc finger 1

1 protein, 71 patents, 0 drugs, 0 trials, 3,715 NIH grants and 5,930 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolIKZF1HGNC
NameIKAROS family zinc finger 1HGNC
NCBI Gene ID10320NCBI Gene
HGNC IDHGNC:13176HGNC
EnsemblENSG00000185811NCBI Gene
AliasesCVID13, Hs.54452, IK1, IKAROS, LYF1, LyF-1, PPP1R92, PRO0758, ZNFN1A1, hIk-1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q13422DNA-binding protein Ikaros51911Ensembl, GeneID, HGNCUniProt

Patents 71

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4781985 A22026-07-291Q13422Espacenet
JP 2026048701 A2026-03-17329Q13422Espacenet
JP 2026505349 A2026-02-133Q13422Espacenet
JP 2026502937 A2026-01-271Q13422Espacenet
JP 2026004568 A2026-01-1449611Q13422Espacenet
JP 2026501039 A2026-01-141Q13422Espacenet
EP 4661970 A12025-12-1762151Q13422Espacenet
WO 2025226767 A12025-10-301Q13422Espacenet
EP 4641201 A22025-10-295643Q13422Espacenet
JP 2025147176 A2025-10-0615162Q13422Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3715

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA021765Cancer Center Support Grant (CCSG)942,025NIH's project files
P30CA008748Cancer Center Support Grant562,025NIH's project files
P30CA016672Cancer Center Support Grant472,025NIH's project files
R35CA197695Translating genomic discoveries to improved outcomes for high risk acute leukemia262,025NIH's project files
U10CA180886COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement262,025NIH's project files
U10CA180899Children's Oncology Group Statistics and Data Center232,025NIH's project files
P30CA016058Cancer Center Support Grant202,025NIH's project files
P50CA186781Mayo Clinic Multiple Myeloma SPORE202,025NIH's project files
R01CA157644Central tolerance mechanisms in B-cell malignancies202,025NIH's project files
P01CA066996Development of Novel Therapeutic Strategies in Human Leukemias192,025NIH's project files

Papers 5930

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42778383PubTator, text miningPubMed
42774342PubTator, text miningPubMed
42771059PubTator, text miningPubMed
42763069PubTator, text miningPubMed
42732828PubTator, text miningPubMed
42720456PubTator, text miningPubMed
42707139PubTator, text miningPubMed
42691457PubTator, text miningPubMed
42677819PubTator, text miningPubMed
42653279PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license